Tugce Nur Yigenoglu
11PUBLICATIONS
73CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Apr 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias.Abdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal
|Sep 13, 2021
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.Bahar Uncu Ulu, Mehmet Sinan Dal, İpek Yönal Hindilerden
|Jun 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.Olga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan
|May 06, 2021
COVID-19 clinical course and blood groups: Turkish population-based studyMehmet Sinan Dal, Naim Ata, Fevzi Altuntaş
|Mar 23, 2021
Recovery of Symmetrical Peripheral Gangrene of Limbs in a Patient After Performing Hemoadsorption in Septic Shock.Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Tuba Hacıbekiroğlu
|Nov 25, 2020
Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experienceHikmettullah Batgi, Semih Başcı, Mehmet Sinan Dal
Pageof 2
Frequent Collaborators
4 joint publications
Mehmet Sinan Dal
4 joint publications
Fevzi Altuntaş
4 joint publications
Bahar Uncu Ulu
3 joint publications
Semih Başcı
2 joint publications
Güray Saydam
2 joint publications
Merih Kızıl Çakar
2 joint publications
Mehmet Hilmi Doğu
2 joint publications
Serdal Korkmaz
2 joint publications
Osman Celik
2 joint publications
Abdulkadir Basturk
